GlassScriptPhysician profile
Vivian Pham
NPI 1497109680
$3,167.39
in general payments reported to CMS, 2019-2025
12 companies · $83.77 in 2025
The $83.77 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,178 · 2021: $766 · 2023: $140 · 2025: $83.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $223.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,854.56 | 2020 | |
| Boston Scientific Corporation | $368.10 | 2020-2025 | Watchman Flx |
| Vertos Medical, INC. | $183.97 | 2021 | |
| Eagle Pharmaceuticals, INC. | $139.70 | 2023 | |
| Relievant Medsystems, INC. | $123.73 | 2021 | |
| Acacia Pharma INC | $106.72 | 2021 | |
| Abbott Laboratories | $84.86 | 2021 | |
| Stryker Corporation | $83.84 | 2020 | |
| Nevro Corp. | $79.70 | 2021 | |
| Stimwave Technologies Incorporated | $62.05 | 2021 | |
| Spr Therapeutics, INC | $52.95 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $27.21 | 2025 | Uzedy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivian Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.